167 related articles for article (PubMed ID: 1727126)
1. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
2. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
3. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
[TBL] [Abstract][Full Text] [Related]
4. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.
Maciejewski B; Withers HR; Taylor JM; Hliniak A
Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):831-43. PubMed ID: 2921175
[TBL] [Abstract][Full Text] [Related]
5. Hyperfractionated radiotherapy in the treatment of squamous cell carcinomas of the supraglottic larynx.
Wendt CD; Peters LJ; Ang KK; Morrison WH; Maor MH; Goepfert H; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Nov; 17(5):1057-62. PubMed ID: 2808039
[TBL] [Abstract][Full Text] [Related]
6. Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx.
Maciejewski B; Taylor JM; Withers HR
Radiother Oncol; 1986 Dec; 7(4):323-6. PubMed ID: 3809591
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer.
Karasawa K; Kunogi H; Hirai T; Hoji H; Hirowatari H; Izawa H; Ito K; Sasai K; Furuya T; Ozawa S; Matsumoto F; Ito S; Oba S
J Radiat Res; 2013 Jul; 54(4):684-9. PubMed ID: 23297315
[TBL] [Abstract][Full Text] [Related]
8. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
Krstevska V; Crvenkova S
Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma of the pharyngeal walls treated with radiotherapy.
Chang L; Stevens KR; Moss WT; Marquez Cm; Pearse HD; Cohen JI
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):477-83. PubMed ID: 8655370
[TBL] [Abstract][Full Text] [Related]
10. Importance of dose per fraction and estimation of an alpha/beta value for the late complications of the vocal cord.
Deore SM; Supe SJ; Sharma V; Dinshaw KA
Strahlenther Onkol; 1991 Oct; 167(10):608-11. PubMed ID: 1948646
[TBL] [Abstract][Full Text] [Related]
11. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85.
Overgaard J; Hansen HS; Overgaard M; Bastholt L; Berthelsen A; Specht L; Lindeløv B; Jørgensen K
Radiother Oncol; 1998 Feb; 46(2):135-46. PubMed ID: 9510041
[TBL] [Abstract][Full Text] [Related]
12. Accelerated radiation therapy, seven fractions per week, for advanced head and neck cancer--a feasibility study.
O'Sullivan JM; Hollywood DP; Cody N; Dillon J; Buckney S; Moriarty MJ; Armstrong JG
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):236-40. PubMed ID: 12109829
[TBL] [Abstract][Full Text] [Related]
13. Late radiation induced laryngeal oedema in the treatment of vocal cord cancer: analysis using the linear quadratic model.
Deore SM; Supe SJ; Sharma V; Dinshaw KA
Indian J Cancer; 1993 Sep; 30(3):113-9. PubMed ID: 8300140
[TBL] [Abstract][Full Text] [Related]
14. Multiple fractions daily for head and neck cancer: spinal cord effects and other late results.
Crellin RP; Macmillan CH; Berridge JK; Morgan DA
Clin Oncol (R Coll Radiol); 1993; 5(3):139-42. PubMed ID: 8347535
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
16. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
17. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiation of free jejunal autografts in patients with advanced cancer of the head and neck.
Cole CJ; Garden AS; Frankenthaler RA; Reece GP; Morrison WH; Ang KK; Peters LJ
Cancer; 1995 May; 75(9):2356-60. PubMed ID: 7712448
[TBL] [Abstract][Full Text] [Related]
19. T1-T2 squamous cell carcinoma of the glottic larynx treated with radiotherapy: a multivariate analysis of variables potentially influencing local control.
Fein DA; Mendenhall WM; Parsons JT; Million RR
Int J Radiat Oncol Biol Phys; 1993 Mar; 25(4):605-11. PubMed ID: 8454477
[TBL] [Abstract][Full Text] [Related]
20. Results of twice-a-day irradiation of squamous cell carcinomas of the head and neck.
Parsons JT; Cassisi NJ; Million RR
Int J Radiat Oncol Biol Phys; 1984 Nov; 10(11):2041-51. PubMed ID: 6490431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
